FDA Releases Topamax Warning Citing High Risk of Cleft Palate Birth Defects: Law Firm Anapol Schwart

FDA Releases Topamax Warning Citing High Risk of Cleft Palate Birth Defects: Law Firm Anapol Schwartz Launches Online Resources for Women and Expecting Mothers On March 4, 2011, the Food and Drug Administration (FDA) issued a news release warning the public about an increased risk of cleft palate and lip palate oral birth defects for infants born to mothers who have taken the antiepileptic drug Topamax (topiramate) and its generic forms. Philadelphia, Pennsylvania (Vocus/PRWEB) March 11, 2011 On March 4, 2011, the Food and Drug Administration (FDA) issued a news release warning the public
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories